NCT05302492

Brief Summary

Humans spend a third of their time on sleep. Therefore, maintaining a deep, stable and consistent sleep is very important for a good quality of life. Aging is often related to a decrease in the ability to fall asleep and maintain sleep. Getting older, various factors can worsen the normal sleep process, which is essential for restoring function and body function. Aging-related diseases, life changes, or own aging can disrupt the normal sleep cycle and seriously affect healthy aging. For example, the circadian rhythm and sleep consolidation will be broken with normal aging. These changes may lead to aging, or become part of the risk factors for diseases such as Alzheimer's disease. How to avoid disability and dementia by improving the quality of sleep to make the elderly healthy and aging, will bring huge effects to the economy, society, and health care. From this plan, investigators will participate in an integrated plan (main plan)-" Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Healthy Aging". In the main plan, 500 subjects will be enrolled. All subjects consent to provide medical record and will be tested for sarcopenia, including body composition, 4-meter walk, handgrip strength. The subjects screened sleep-affected subjects. It is estimated that 250 people will be invited for home sleep testing, such as continuous positive pressure breathing aid (CPAP) for sleep apnea (OSA) (approximately 120 subjects). For non-OSA and non-periodic limb movement disorder (PLMS) sleep problems, take a phototherapy program (about 60 subjects). The following goals are expected to be achieved:

  1. 1.Link to the main project to explore the correlation between common sleep disorders in the elderly and blood pressure, cognition, sarcopenia, metabolomics or intestinal microbiome
  2. 2.To verify the prognosis of sleep apnea and sleep disorders after intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 17, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

February 7, 2024

Status Verified

May 1, 2023

Enrollment Period

2 years

First QC Date

February 11, 2022

Last Update Submit

February 5, 2024

Conditions

Keywords

agingsleep disturbanceCPAPphototherapyomics

Outcome Measures

Primary Outcomes (1)

  • Change from baseline PSQI ( Pittsburg Sleep Quality Index ) at 3 months

    Subjective sleep quality will be assessed by the PSQI questionnaire. The measure consists of 19 individual items, creating 7 components that produce one global score. Each component is weighted on a 0-3 interval scale. The global PSQI score is then calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality.

    3 months

Secondary Outcomes (7)

  • Change from baseline sleep efficiency at 3 months

    3 months

  • Change from baseline total sleep time at 3 months

    3 months

  • Change from baseline sleep onset latency at 3 months

    3 months

  • Change from baseline wake after sleep onset (WASO) at 3 months

    3 months

  • Change from baseline appendicular skeletal muscle mass at 3 months

    3 months

  • +2 more secondary outcomes

Study Arms (2)

Sleep apnea group with CPAP

EXPERIMENTAL

Intervention group: CPAP for 3 months in elderly diagnosis with sleep apnea and AHI \> 15/h. Control group: sleep apnea and patient refuse treatment or poor compliance.

Device: CPAP

sleep disturbance without sleep apnea nor PLMS

EXPERIMENTAL

Intervention group: light box on elderly with sleep disturbance with PSQI \> 5 and no OSA and no PLMS control group: elderly with sleep disturbance with PSQI \> 5 and no OSA and no PLMS refuse light box or poor compliance

Device: Light box

Interventions

CPAPDEVICE

CPAP: continue positive airway pressure ventilator is the standard treatment of OSA.

Sleep apnea group with CPAP
Light boxDEVICE

Light box: is the treatment choice for circadian rhythm disorders. now apply to sleep disturbance without OSA or PLMS.

sleep disturbance without sleep apnea nor PLMS

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Those who are willing to sign the written subject consent
  • Participants who participated in the integrated project (main project) - "Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Healthy Aging"
  • The results of the sleep questionnaire meet one of the following:
  • Pittsburgh Sleep Quality Scale (PSQI) \> 5 points
  • The Self-Sleep Assessment Questionnaire (STOP-BANG) is at high risk for sleep apnea (OSA)

You may not qualify if:

  • Patients with severe cataracts who have not received treatment, patients with color blindness and chronic skin diseases (including psoriasis, eczema), or those who are considered by the host to be unable to receive light therapy.
  • Those who are unsuitable after evaluation by a physician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, 333, Taiwan

Location

MeSH Terms

Conditions

Parasomnias

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Ning-hong Chen, MD

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2022

First Posted

March 31, 2022

Study Start

May 17, 2021

Primary Completion

May 31, 2023

Study Completion

May 31, 2023

Last Updated

February 7, 2024

Record last verified: 2023-05

Locations